Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well, suckitup, I've never been a fan of the ALL CAPS writing style, and I try not to hurl insults at folks I prefer to think of as teammates in this crazy endeavor. And I don't believe this board has fully transcended to the depths of full "joke" status yet, but we are wading waist-deep in those waters. A shot or two of better news will help turn around some of the soured attitudes on this board. Unfortunately I don't foresee any such announcements at AGM, unless a financing or partnering agreement is a done deal. Once something good happens, I think this board will return to its former state as a source of valid information.
Other than those points, I personally think your post is right on the mark in that it matches my opinion on each of the other points you expressed.
1. Patel's disappearance from the SAB list has been explained and therefore no longer qualifies as "evidence" of anything.
2. Almost out of funds; fundraising regardless of R/S means substantial dilution and needs to happen long before an uplist is possible.
3. McNally's history is evaluate, plan, and execute. Evaluate and plan were done before he took the job. Execute is what he does best.
4. SPORT IS the real deal. Patents tell us what the pieces do. Seeing the pieces together means we know what the unit as a whole can do. Operational software exists to make the unit work; now it needs safety and redundancy features in software to meet FDA scrutiny. It is all coming together!
5. I would love to disagree with point number 5 because I think the future rewards for us longs would be greater if Titan remained a solo act, but that just isn't in McNally's historical playbook.
6. This is another one I'd love to disagree with, but history is against us, on top of the fact that the market still sees this as a penny stock regardless of number of shares and actual value of the company and tech. I expect an R/S, a drop, then eventual recovery.
7. I bought what I could and would pick up more if I had the resources. At least the post-R/S drop will give us one last opportunity.
8. A hospital needs to contact a realtor to buy enough floor space for a Senhance system!
9. ISRG paved the road; time to deliver before the pavement crumbles any further!
Quoted post:
THIS BOARD HAS BECOME A JOKE...IF YOU ALL WOULD LIKE TO CHAT LIKE LITTLE GIRLS THEN DO IT ON FACEBOOK...FOR THE SERIOUS INVESTOR HERE ARE MY THOUGHTS:
1.PATEL IS STILL ON THE SAB
2.WE ARE ALMOST OUT OF MONEY
3.MCNALLY HAS A PLAN
4.SPORT AS SHOWN BY TITAN IS THE REAL DEAL
5.TITAN IS NOT COMING TO MARKET...THEY ARE TRYING TO BE SOLD
6.THE PRICE WILL DROP ONCE RS AND UPLISTED..
7.BUY AS MUCH AS YOU CAN AT THIS POINT..LAST CHANCE
8.TRANSENTERIX IS A COMPLETE JOKE...GIANT FOOTPRINT
9.ISRG HAS PAVED THE ROAD FOR TITAN..TIME TO DELIVER
Hi Slick,
I had a short list of questions to include in a letter but the effort seemed to lose its drive pretty quickly. Contributions were quite limited and it was difficult to rationalize how to make the points contextually meaningful without being redundant with their anticipated AGM presentation.
A quick sample of inputs offered for the letter:
DRG1025: Flenderson said there is a plan to keep PPS rising; will management share the plan with shareholders? Also, how does the uplist draw in new investments (is it a plan or a Hail Mary pass)? My take: they will share as much of the plan as they are willing to at the AGM.
JMAC13: Need new video of SPORT in a realistic surgical situation. My take: entirely true and most likely can/will occur once the three sites are up and running. It would be nice to hear that it is on their radar screen; I think this really needs to be tied to a broader question about marketing the investment opportunity and using video demonstrations with other publicized materials to display SPORT's capability to improve all aspects of robotic surgery.
Hypocrates: Should shareholders perceive Titan Management's lack of stock purchases as lack of confidence? My take: very valid question but could be viewed as getting too personal, which could shut us out completely. If we wanted to go that route, we could also ask them how many board members have recommended Titan stock to friends and family? I think that would be even more indicative of their confidence levels.
All good questions, and my thanks to all the contributors (there were a couple others too but on another list which is on my home PC). I'm keeping the lists and hoping to see what falls out of the AGM, at which point maybe a well composed letter can also use their AGM statements to help pry further details from them.
I evaluated the possibility of attending the AGM myself - the cheapest travel option from NH is driving, plus an overnight stay and two days lost wages (no vacation time as a contractor). With two kids in an expensive engineering college and a quarterly tax payment due in a week, this just isn't a good time for me to take a $2500+ financial hit.
If someone here does plan to attend, I would be more than happy to help compose a few questions which could be presented in person (and save Hypocrates' question for last!).
Honestly, I'm not sure what to expect. I can only assume that if there are no other funding strategies playing out in the background right now, we need to dilute further. At .25/share, that is really ugly. I would expect funding to be sought in increments with hopes that share price can rebound in the meantime. At .25 price, $70M is another 280M shares, so current shareholders get their percentage of the company diluted down to 0.4 times their current ownership if they try to do it all at once.
It would not surprise me if certain topics such as dilution are left out of the AGM discussion unless someone asks specifically about them. Given that the voting includes authorization for the reverse split, I assume that will be addressed, and with sufficient positive spin. The AGM is their opportunity to explain why they need it and how it will help; they might not delve too deeply into the risks it also poses. I'm not saying this to be critical of current management, I just think it is a fairly natural expectation given their situation.
I think we need to try to drive home the point to them that if this project is really about the technology (as most of us believe) then we need to see some indication of the technology. We need to see evidence that this device is capable of doing what it is expected to do, at least to the extent they can share such evidence. I know there are substantial limitations on what they are allowed to claim about a non-FDA approved device. But if they have surgeons playing with the device, get a couple statements from these docs, have the statements vetted by the legal team, and put them out there to show that SPORT is the real deal and will be as desirable to the marketplace as we all hope it will be. Until we can get some public verification that this is what it looks like, the share price will continue to flounder in the 20 cent range and continue to get played by the shorters and market makers.
All just my opinion, obviously...
Is anyone here definitely going to AGM?
I do find the lack of information a bit disturbing, but I don't have any evidence that the new management team is lying to us. There seems to be a rapidly growing distrust here on the message board, as well as a diminished outlook, despite no real change to drive those viewpoints downward. Particularly with AGM so close, we should not be expecting any sort of announcement unless some huge breakthrough happens to hit between now and then, and this is a bit premature for that type of a breakthrough. The sole exception I can think of is something which resolves our imminent funding issue. Not likely in the next two weeks.
I don't know for sure what the management team's viewpoint is on Mr. Randall except that they think highly enough of him to want to add him to the BOD. As our votes are coming in recommending otherwise, they might be feeling a bit disappointed, if not betrayed by us. Hopefully it will give them sufficient reason to reevaluate their nomination.
I have been compiling a list of questions from the past week or so and will put it all out here next week for comments, additions, and of course a volunteer or two who can go the the AGM and press these issues. I think at this point another letter would serve us better after the AGM, when they have the opportunity to address our concerns and put forth a plan which will surely raise additional questions. At that point, a letter regarding the plan would likely be more meaningful for us and for them. Meanwhile, feel free to post more questions for the list. And be well.
I would love to go but unfortunately I don't think I can. Might not be the greatest point in my project timeline for a couple days off, and as a contractor, if I don't work, I don't get paid. But that doesn't mean I wouldn't LOVE to go. I would have our list of questions, and a pen to jot down notes during the presentation and cross off those which get answered therein. The rest would get asked as long as they don't shut me down and walk out of the meeting first!
If I could go, I'd love to take my wife too; she would probably be looking for someone to ask more technical questions to about the robot and the OR logistics... might be an area they are relatively weak in at this point. Hell, maybe she should apply for the BOD position in place of Randall! They could use someone with her background to know what the buying hospitals will really want and need! (Hey, how much does a Director get paid???)
Flenderson,
Given your unique insight into some of our tribulations as shareholders, are there a few specific questions or topics that you would recommend we try to get answered at the AGM? If we can get someone there, there are certainly some questions which would be much more poignant than others. Maybe there are some topics you know of that we aren't even aware of at the moment but really should/would like to know about. Thoughts?
Thanks!
I did the same on all three of my accounts; yes to everything but Randall. I don't know the guy, never met him or talked to him. But to the best of my knowledge, Titan's technology is first rate, and the biggest issue this program faces today is the same one it has faced for the past three years, which is the financial side. Without knowing the guy or knowing any specific benefits he might bring to the BOD, I just can't figure out why he should be elevated to that position.
Regarding everything we are voting on, if we put up a relatively unanimous front, it will be interesting to see if we actually have any real influence on these issues. My assumption is that our "almost 6%" of shares will be far fewer than those which people don't bother to vote with - folks that just throw away the envelope; I assume their votes are automatically tallied for whatever management recommends, which is yes to everything. If for some reason Randall does not make it to BOD, then maybe our sphere of influence (including non-contributory readers of this message board; I was one of them for a couple years) has more legs than we realize.
Medtronic was featured in a number of articles last summer saying the same thing - Robot nearly done; revenue in 2019.
http://www.reuters.com/article/us-medtronic-robot-idUSKCN0YS2C3
https://www.forbes.com/forbes/welcome/?toURL=https://www.forbes.com/sites/greatspeculations/2016/06/13/how-will-medtronics-success-in-the-surgical-robot-market-be-determined/&refURL=https://www.bing.com/&referrer=https://www.bing.com/
http://www.mddionline.com/blog/devicetalk/finally-details-medtronics-robotics-platform-06-08-16
They get a bump in PPS for regurgitating year-old news. Go figure.
Maybe the question could be phrased something like "Does the Titan management team's refusal to buy shares of stock on the open market not imply a lack of confidence in the future of the product and the company, and why should investors not perceive it this way?"
I did No on Randall and Yes for reverse split, only for my Scottrade account so far. I have two more for Wells Fargo accounts which came in yesterday; I plan to do the same. I don't really know what specifics Dr. Wolff is bringing to us in term of benefit or activity at the moment but once we get into clinical trials, I can see definite benefit to having some surgical experience on the BOD. If the Board is entirely non-clinical, it could be easier for them to overlook something that is more important in the OR than the businessmen would realize.
And Mr. Barker pulled through for us when we really needed him last fall, so he still gets my support.
I'm on board with another letter before the AGM, but we need to get our list of talking point together. Like last time, please begin any posting with "For the letter" and I'll build a list!
Just a longshot theory I only bring up because of the coincidence and the single port discussion...
In ISRG's early days, they were plagued by a patent infringement case from Computer Motion, so ISRG bought CM and went on their merry way.
ISRG now has a single port device but it is not being marketed. Could it be that Titan's patent portfolio for single port is the issue? If so, history was that ISRG bought out the company with the IP. Another way to go would be for Titan to license the IP non-exclusively to ISRG, let's say for a $70M down payment and royalties on all ISRG single port sales and on cases performed. And still allows us to compete when we get there!
One can dream, can't one?
Maybe that answers the question about where at least ONE of the SPORT systems is currently located!
Hargrove, Reiza, Fowler... Still the whipping boys on the message board. Certainly there are things they could have done differently. But without them, there never would have been a product at all. And Amadeus could have been the next ALF-X or Senhance. With Amadeus as far along as it was, they had the foresight to see a better way with the SPORT concept, even at the cost of so much prior development work getting tossed out the window (a lot of it surely was still applicable so Amadeus wasn't really a total loss). Think about having to make the decision they did to shift over to SPORT. It must have been soul crushing to trash years of hard work and go back to square one on a different platform. Sometimes the hardest decisions reap the biggest rewards. Painful for investors like me and most of us who wanted to see a return on investment sooner rather than later, but when we look back 5 years from now and compare Titan to TRXC, we just may discover we really owe those guys a pat on the back and an honest handshake. Without them, we'd be TRXC at best.
Surely those guys still hold shares and still want whatever is best for this program, which was once their baby. Maybe McNally is getting the train back on the right track, but before him, someone built the train.
Maybe it's time we ease up on the prior team.
Agree mostly... I still have some trepidation about the potential downsides for the RS but I also see the upsides, and I figure McNally and crew know better than I ever will. I would most likely vote yes on the RS if the vote were to happen today.
I have also been thinking for a while that we are on the verge of reaching many important milestones. The real drivers for stock price increases are ahead and getting closer every day/week/month.
Still all in, still long, would still be buying if I had the funds.
I'm in Hooksett NH, just above Manchester. About 30 minutes above Nashua. And my brother lives in Milford!
And Rebster's brother lives in my neighborhood, right around the corner!
Where are you from?
Sorry about delayed reply; was out for the day.
Wife's background... OR Tech while working through nursing school, followed by BS in Business Management and then her MSN. RN/OR since 1987. OR Nurse Educator, various management positions, currently Business and IT Manager as well as Infection Control for Surgical Services. Was one of the first RNs in NH trained on da Vinci; precepted dozens of others as department Educator for her staff and for several outside organizations buying early da Vincis. Like most ORs, hers is short staffed so she still spends more time in the rooms than she should. I'm not the only one in the area who trusts her judgement on most things surgery-related.
Wow... I just logged in. The last post I read yesterday was just before the AGM announcement was posted. Catching up took a while! Not to mention digesting what may happen.
Since my background is all medical devices and very little investing, I have been all about the technology from day 1. I see this tech as a winner; I have had my wife with more robotic experience than most also looking at it all along (she is the one who first heard about Titan to begin with) and saying it is a true need. Just like when she told me da Vinci should be a hit because it can reliably spare the nerve bundle during prostatectomy so men can continue to have sex. Most men like sex, I thought, so she is probably right. Paid $11.65 for my ISRG shares (and unfortunately got out at $750/share). I mentioned I'm not strong in investment...
This time she is telling me single port, 3D vision, and the flexibility of the arms is extremely desirable in surgery. The relatively compact footprint, ease of handling, and cost savings are all just icing on the cake. This product will not fail on concept, it can only fail on execution. McNally executes. My confidence remains strong.
Okay, I was never a big fan of a reverse split. Always seemed to be like it drives the price up, giving it more room to fall back down. Almost like it could have some natural tendency to return to $.30 regardless of number of shares or Market cap or actual value. But in this case, uplisting seems like the natural path, and maybe sooner is better than later in terms of fundraising capability.
That old article saying Titan is worth $4/share for the technology alone still sticks in my mind. A 30:1 reverse split means we are looking at $9/share, about 6.2M shares, and same initial market cap. But the value analysis (per the article) per share would then work out to be $120/share. For me, the value proposition is everything. $9/share, or $6 with a 20:1 RS, is still the same value, and the idea of the share VALUE (technology based value) still being 15 times the current price is VERY attractive, regardless of what mathematical factor it may be scaled by.
With a market cap of about $60M and the need to raise $70M, we are looking at a dilution of over 50%. But the value proposition still supports that with huge profits available to those who believe - if, of course, they don't screw up.
So at this point there is a bit of blind faith in McNally, added to his track history and the backgrounds of the folks he has been bringing and continues to bring on board, maybe not entirely blind faith, some is earned faith. Some RSs turn to crap and some are big successes. It would be interesting to know (anyone going to AGM could ask!) if McNally had the reverse split in mind when he first came on board or if other obstacles to funding pushed him in that direction.
SPORT meets criteria for clinical, financial, and technological evaluations. People already want this product. The numbers work in our favor regardless of split or not.
CUIN2, sorry to see you leave. You were a valuable contributor; I respect your opinion even if I don't always share it (usually I did!). Be well!
You don't think they will sell any on their own?? You mean to say that all Paige's hard work is for naught??
Not a problem... I put you down as 138K to get over 5%, with a footnote. I was less concerned about any individual holdings and more about the totals, to gauge what kind of influence we might have with Titan just in case it doesn't go swimmingly from here. We are mostly anonymous out here anyway except for Rebster and I going for a couple beers now and then. Maybe for the Vegas party we can all wear nametags with our user ID and a first name only!
Sorry... that was supposed to be "18 or 48 months ago..."
I'm with Times Yours on this... it's a whole new team with a real proven track record now. What happened 18 or 18 months ago is old news and has no bearing on the future of this company. It did eventually, through a tortured path, get the technology to where it is today. Most of us were riding along through the torture; the most pain now seems to be inflicted upon us by whatever demon is keeping our share price suppressed. That has to break when major milestones are crossed.
As for the list... Currently at 9,261,895 shares and 4.93% of outstanding shares. 138K shares away from the 5% mark, based on people who posted on this little board in one day. I'll keep the list running if more people want to send their info.
Per my request, I had my wife evaluate the video which scalpel had posted earlier today. She has over 3 decades of OR experience and was instrumental in bringing da Vinci to NH when it first came out. She had a few observations:
I had previously commented on the instability of the clip applicator in the video. She noticed it was a manually operated instrument, not part of Senhance. My bad! So I had to make that the first point here.
Otherwise, she fully agreed at how ludicrous it is to have all that floor space and working space occupied by those monstrous towers. She expressed some rather critical concern about patient inaccessibility.
She noted that there is no wristed instrumentation or flexibility within the surgical space and that the motion of the instruments offers no advantage over a laproscopic procedure. The motion of the instruments works the hell out of the incisions and will probably cause undue bruising and discomfort for the patient over the next couple days.
She agreed that the wild overshoot of motion of the cutting tool is also extremely undesirable; she attributed that as most likely being a training issue where the surgeon is applying too much force to the cutting device, such that when the tissue releases tension, it goes flying beyond the cutting site. The RF energy should do the cutting and almost no additional force should be applied by the surgeon.
The surgeon sitting at the console is holding his arms up in front of him for the entire duration of the procedure. Very tiring, and by the end of the procedure, control may become much more of an issue. Given that his control of the device appeared suboptimal at the beginning of the procedure, I wouldn't want a lengthier procedure performed with Senhance.
The surgeon also tended to lean forward occasionally as if it would offer a better view. He is looking at a flat screen through 3D glasses. Leaning closer to the screen cannot change his perspective or improve his visibility.
Lastly, and presumably unrelated to Senhance, there were a couple people in the OR without masks or hair coverings. It would seem the requirements in the UK are substantially less stringent than here in the US. If you have a choice, I recommend staying stateside if you need surgery.
I love my wife dearly. She is very intelligent and apparently also quite observant, with the ability to be quite critical. And yet she keeps me anyway!
About a year ago, an evaluation was published showing the patent portfolio alone was worth around $4 per share at that time. To be fair, it certainly must be disclosed that Titan paid for the evaluation to be done, so one could question the veracity of their conclusions. However, the logic seemed sound and their comparative basis also seemed reasonable and correct. The direction the company has gone since then appears to be putting them in a position of better strength than that of a year ago. With the recent completion of Human Factors Engineering evaluations (the very thing which got Transenetrix shot down by the FDA last spring) that position appears to be even stronger moving forward. We (or I, at least)presume their recent completion of an IP portfolio review should have identified any potential patent conflicts, and the report was all positive so they presumably will have a fairly clear pathway to FDA approval when they are ready.They have been working with the FDA for years to help ensure approval, and had previously indicated that their plan to file a 510K with a predicate device also had FDA buy-in in advance. And they have had a couple more patent approvals come through in the past year.
That all being said, it's a crazy world out there. Believers on this message board seem to fall anywhere from $10 to $30 per share in their states hopes for PPS. I think it is more a matter of how long one wants to wait. FDA approval has to spike this up substantially, and the pathway getting to that point should have us passing enough substantial milestones that PPS would escape the grasp of the market makers and force itself up to something more in line with actual value of the technology.
I'm thinking, in direct response to your question, and just my opinion, of course... the $3 minimum you seek should be a slam dunk by next summer or fall; the announcement of the FDA filing near the end of the year should easily clear your $5 benchmark; and a couple years beyond that should easily exceed your "amazing" level by a good margin. And $10 a share is about when I can no longer be convinced to work any more. I'm in this for a shortcut to retirement. And a big party in Vegas!
Good luck to all of us!
Last update for the evening... but if there are more additions tonight, I will catch up in the morning.
48 shareholders reported
8,656,895 shares total
4.605% of outstanding shares
Avg. shares per reported shareholder = 180,352
Side note: Agree, nice article! I don't agree with his assessment of the Senhance system, but otherwise all good!
Heading home soon... will update the tally tonight or worst case tomorrow morning.
So far, we are 42 shareholders with appx. 8.2M shares or 4.36% of the outstanding shares. So far.
I'll add to the list any time someone wants to chime in; also, if you buy or sell, I can only revise the numbers if you tell me. Hopefully buy, not sell.
I certainly agree with your assessment of Senhance. The video could be used as a marketing tool by Titan when we get to market.
OR staff ducking under the big arms and around the huge bases. Up to four of them supported at a time means no more physical or visual access to the patient.
Just past the 1:00 mark, cutting through tissue, the tissue releases its tension and the cutter goes flying well past the active cutting site, out of control. And presumably dangerous.
At 2:10, the grasper is opening and closing repeatedly before contacting the tissue, from which one must infer that depth perception is an issue despite the supposed 3D display.
Around 2:30, the larger manual clip applicator is twisting and flailing randomly as if some feedback loop has lost an input signal. Crazy stuff!
Around 3:15, the entire giant horizontal beam is rising and falling substantially. Does not appear to be out of control but I find it difficult to rationalize why relatively small movements within the surgical field should require such drastic motion of those huge arms. Unless they are warming up for a limbo contest. Did I hear "Limbo Rock" playing in the background? Or is there a Challenge Mode for the anesthetist to get back to his cart?
Just Wow.
As for the running tally, currently just shy of 8M shares, and over 4.18% of the company. For some of the new names we are seeing, welcome aboard, and we hope to hear more from you!
That just pushed us over 6M shares! 3.2% of Titan has sent in numbers so far.
So far...
Investfor5years 1,200,000
66Mustang 275000
scalpel 350000
adrock 150000
none65 250000
Magnetics 258500
9435hh 82000
BigT82 120000
DMAC01 100000
hubwolf1 550000
pmontx 110000
BrooklynHardhead680000
BobbySixty 868000
CUIN2 14
ORep8 150000
DRG1025 45351
Bronzo 154000
Total so far 5,342,865
Getting close to 3% of the company.
Just for clarification... a msiplaced comma would mean that's 25k or a missing 0 means 250K. I'll assume 250K unless you say otherwise!
Investfor5years 1,200,000
66Mustang 275,000
scalpel 350,000
adrock 150,000
Almost 2 million shares from four people who happen to be awake this early! Over 1% of the company already.
I only get 15 posts per day so I'll be compiling the list and post the update periodically.
Investfor5years 1,200,000
66Mustang 275,000
scalpel 350,000
Do we want to figure out what we do have? We can run a quick tally of whomever wants to participate... Cut and paste the list and add your own info to it, and by the end of the day we should have a pretty fair idea if we have any genuine leverage with Titan.
Investfor5years 1,200,000
66Mustang 275,000
Could turn into a pretty cool little experiment!
I thought Jasminder led a comprehensive IP Review earlier this year for McNally. That should have weeded out any potential infringement issues. Also, a thorough IP review is a reasonable request by any company looking to buy... Not that I want to feed that particular fire.
Hi Joecanada! Welcome from me also. We can always use good input and more visibility. We have a diverse contributor base including a range of OR experience, some medical device development, and some from the investment community, and others who for various reasons stumbled across Titan Medical and believe in the technology. For the most part this is a great board in which everyone can learn something about the areas they are not as strong in. There is typically a bit of bickering that does go on as folks share their differences of opinion, but we are all focused on seeing the product get to the marketplace and obviously, the stock price bringing us all closer to retirement. Oh, yes... we have generic plans for a big party in Vegas when it all comes to fruition!
If you have read back a bit on our postings, you may have picked up on this already, but if not you will note that the big issues most discussed on the board tend to be the following:
Is the new management team going to bring this program to a successful conclusion?
How will funding be handled moving forward?
Would a reverse split and possible uplisting be beneficial?
Are new members of the Surgeon Advisory Board (prominent/respected surgeons in their respective specialties) good indicators of Titan's future?
Will Titan partner up or be bought by another major player (Verb being the most discussed possibility)?
Not sure about your background or your involvement with Titan as a shareholder or otherwise interested party, but we would certainly welcome any input you have to offer!
I hope TRXC's Sales positions aren't commission-based compensation. A behemoth system like that should be a tough sell! Four giant pods restricting access to the patient...
TRXC's crash was April 28, so we'll see in a couple weeks if delisting begins. They are down about 3.4% at the moment for today. Barring any huge sales announcements, I can't see anything bailing out the TRXC ship between now and then.
My apologies for the off-topic post but I have been watching TRXC for a while in case I see a good opportunity. I think there will be one but I'm fairly sure it is not quite yet.
The answer? No, clearly not. A partial solution? I believe in it. If it doesn't help at all with luring other investors, it at least helps keep us from hating each other and feeling miserable.
I appreciate the shout-out, but I refute anything resembling a position of leadership. I try to apply logic to things that don't always follow logical trends, and I try to remain respectful with an occasional humorous observation to keep the tone on the board a little lighter, especially when things are looking darker than they should.
ST on the other hand remains a stalwart of the board, digs for info that isn't always obvious, shares his due diligence generously, and applies OR experience with genuine insight. Trolls will troll, but the majority of us here are just doing our best to contribute in a positive way.
I still firmly believe that maintaining a positive tone here in a public forum is among the best things we can do for our investments as well. If we appear to be intelligent, happy people, others are more likely to drop a few bucks into TITXF to join the club!